Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia

Caterina Mezzatesta(University Children's Hospital Zurich), Beat Bornhäuser(University Children's Hospital Zurich)

Frontiers in Cell and Developmental Biology

March 19, 2019

10.3389/fcell.2019.00040

Cited by 12

Related Papers

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

|Blood|2009|347

Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance

|Journal of Clinical Investigation|2010|311

<i>IKZF1</i><sup>plus</sup>Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

|Journal of Clinical Oncology|2018|304

Efficient apoptosis requires feedback amplification of upstream apoptotic signals by effector caspase-3 or -7

|Science Advances|2019|274

Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia

|Blood|2017|263